Mergers & Acquisitions ·
FOXO Technologies Inc. subsidiary Vector BioSource, Inc. entered into an asset purchase agreement with Grifols Bio…
FOXOWFoxo Technologies Inc.
FOXO Technologies Inc. subsidiary Vector BioSource, Inc. entered into an asset purchase agreement with Grifols Bio Supplies, Inc. to acquire four U.S.-based blood collection centers for $3,500,000 in cash plus a contingent earn-out of up to $1,000,000 based on EBITDA performance between 2026 and 2028. The transaction is subject to regulatory approvals including new FDA and CLIA certifications. FOXO Technologies Inc. operates in the biotechnology and life sciences sector, focusing on blood collection and biological asset management.